Enzymuria in neonates during treatment with tobramycin or ceftazidime.
D000118:Acetylglucosaminidase / Q000652:urine*; D000626:Aminopeptidases / Q000652:urine*; D018826:CD13 Antigens; D002442:Ceftazidime / Q000009:adverse effects* / Q000627:therapeutic use; D006596:Hexosaminidases / Q000652:urine*; D006801:Humans; D007231:Infant, Newborn; D007668:Kidney / Q000187:drug effects / Q000201:enzymology; D018805:Sepsis / Q000188:drug therapy / Q000201:enzymology / Q000652:urine; D014031:Tobramycin / Q000009:adverse effects* / Q000627:therapeutic use
D002442:Ceftazidime; D006596:Hexosaminidases; D000118:Acetylglucosaminidase; D000626:Aminopeptidases; D018826:CD13 Antigens; D014031:Tobramycin